BridgeMD
Compares treatment options for Hallux Valgus
Official title A Study to Compare Early and Partial Weight-bearing After Hallux Valgus Surgery
ClinicalTrials.gov ID: NCT05534724
What this study is testing
- What it's testing
- This is a two-arm randomized controlled trial with the aim to evaluate the effectiveness and safety of post-operative management after a modified Lapidus arthrodesis with/without an Akin or a Weil/Hohmann surgery fusion with immediate complete weight-bearing compared with partial weight-bearing (10 - 15kg) for 6 weeks as a novel approach for rehabilitation after a foot surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Patient who undergo modified Lapidus arthrodesis operation and associated with:
- Additional surgical gestures such as e.g. interventions on the proximal phalanx of the first finger (Akin) or interventions on the 2nd and / or 3rd...
- Willingness and ability to participate in the trial
- Signed Informed Consent
You likely can't join if
- Diabetes mellitus
- Rheumatoid arthritis
- Previous foot surgery
- Classic Lapidus surgery
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the...
- Inability or contraindications to undergo the investigated intervention
See the full eligibility criteria
- Patient who undergo modified Lapidus arthrodesis operation and associated with:
- Additional surgical gestures such as e.g. interventions on the proximal phalanx of the first finger (Akin) or interventions on the 2nd and / or 3rd ray (Weil / Hohmann) [23,24].
- Willingness and ability to participate in the trial
- Signed Informed Consent
- Diabetes mellitus
- Rheumatoid arthritis
- Previous foot surgery
- Classic Lapidus surgery
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the participant, etc.
- Inability or contraindications to undergo the investigated intervention
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Lugano, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lugano, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.